Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Bristol Myers Squibb Company (BMY : NYSE)
 
 • Company Description   
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products. It offers products which includes hematology, oncology, cardiovascular and immunology. Bristol-Myers Squibb Company, formerly known as Bristol-Myers Company, is based in New York.

Number of Employees: 32,200

 
 • Price / Volume Information   
Yesterday's Closing Price: $76.91 Daily Weekly Monthly
20 Day Moving Average: 15,496,662 shares
Shares Outstanding: 2,129.06 (millions)
Market Capitalization: $163,746.34 (millions)
Beta: 0.49
52 Week High: $78.43
52 Week Low: $53.22
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 0.21% 9.80%
12 Week 13.86% 23.54%
Year To Date 23.35% 46.69%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
430 E. 29TH STREET 14 FLOOR
-
NEW YORK,NY 10016
USA		 ph: 212-546-4000
fax: 212-546-4020		 john.elicker@bms.com http://www.bms.com
 
 • General Corporate Information   
Officers
Giovanni Caforio - Chairman and Chief Executive Officer
David V. Elkins - Chief Financial Officer
Karen Santiago - Senior Vice President and Corporate Controller
Peter J. Arduini - Director
Julia A. Haller - Director

Peer Information
Bristol Myers Squibb Company (CORR.)
Bristol Myers Squibb Company (RSPI)
Bristol Myers Squibb Company (CGXP)
Bristol Myers Squibb Company (BGEN)
Bristol Myers Squibb Company (GTBP)
Bristol Myers Squibb Company (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 110122108
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 07/27/22
Share - Related Items
Shares Outstanding: 2,129.06
Most Recent Split Date: 3.00 (2.00:1)
Beta: 0.49
Market Capitalization: $163,746.34 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 2.81%
Current Fiscal Quarter EPS Consensus Estimate: $1.91 Indicated Annual Dividend: $2.16
Current Fiscal Year EPS Consensus Estimate: $7.57 Payout Ratio: 0.28
Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: -0.10
Estmated Long-Term EPS Growth Rate: 6.24% Last Dividend Paid: 03/31/2022 - $0.54
Next EPS Report Date: 07/27/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 10.16
Trailing 12 Months: 9.96
PEG Ratio: 1.63
Price Ratios
Price/Book: 5.17
Price/Cash Flow: 6.20
Price / Sales: 3.49
EPS Growth
vs. Year Ago Period: 12.64%
vs. Previous Quarter: 7.10%
Sales Growth
vs. Year Ago Period: 5.19%
vs. Previous Quarter: -2.81%
ROE
03/31/22 - 48.37
12/31/21 - 45.60
09/30/21 - 43.05
ROA
03/31/22 - 15.80
12/31/21 - 15.20
09/30/21 - 14.24
Current Ratio
03/31/22 - 1.32
12/31/21 - 1.52
09/30/21 - 1.47
Quick Ratio
03/31/22 - 1.23
12/31/21 - 1.43
09/30/21 - 1.36
Operating Margin
03/31/22 - 36.52
12/31/21 - 36.33
09/30/21 - 35.44
Net Margin
03/31/22 - 13.31
12/31/21 - 15.08
09/30/21 - -11.89
Pre-Tax Margin
03/31/22 - 15.45
12/31/21 - 17.46
09/30/21 - -9.26
Book Value
03/31/22 - 14.86
12/31/21 - 16.22
09/30/21 - 16.80
Inventory Turnover
03/31/22 - 4.50
12/31/21 - 4.76
09/30/21 - 5.04
Debt-to-Equity
03/31/22 - 1.18
12/31/21 - 1.10
09/30/21 - 1.06
Debt-to-Capital
03/31/22 - 54.20
12/31/21 - 52.38
09/30/21 - 51.56
 

Powered by Zacks Investment Research ©